The direct measurement of 3-β-hydroxybutyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 16, Issue 5-6, 2003, Pages 312-316

  Vanelli, M ^a   Chiari, G ^a   Capuano, C ^a   Iovane, B ^a   Bernardini, A ^a   Giacalone, T ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

hydroxybutyrate; Diabetes; Diabetic ketoacidosis; Ketosis

Indexed keywords

3 HYDROXYBUTYRIC ACID; BICARBONATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; KETONE BODY;

ARTERIAL PH; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIAGNOSTIC KIT; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KETONURIA; LABORATORY TEST; LENGTH OF STAY; MALE; NURSE; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TIME MANAGEMENT; WORKLOAD;

3-HYDROXYBUTYRIC ACID; BLOOD GLUCOSE; CHILD; COST-BENEFIT ANALYSIS; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROGEN-ION CONCENTRATION; INTENSIVE CARE; KETONE BODIES; MALE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0842325046     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Edge J.A., Ford-Adams M.E., Dunger D.B.: Causes of death in children with insulin-dependent diabetes, 1990-96. Arch. Dis. Child. 81: 318-323, 1999.
2. Daneman D.: Diabetes-related mortality. A pediatrician's view. Diabetes Care 24: 801-802, 2001.
3. Holl R.W., Swift P., Hougaard P., Lynggaard H., Mortensen H.B.: Clinical characteristics of newly diagnosed Type 1 diabetes mellitus mellitus in children and adolescents from 19 centres. J. Ped. Endocr. Metab. 14 (Suppl. 3): 1033, 2001.
4. Vanelli M., Chiarelli F.: Treatment of diabetic ketoacidosis in children and adolescents. Review. Acta Biomed. Ateneo Parmense 74: 59-68, 2003.
5. Laffel L.: Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15: 412-426, 1999.
6. Csako G.: False-positive results for ketones with the drug mesna and other free-sulfhydryl compounds. Clin. Chem. 33: 289-292, 1987.
7. Byrne H.A., Dornan T.L., Tieszen K.L., New J.P., Hollis S.: Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care 23: 500-503, 2000.
8. Stephens J.M., Sulway M.J., Watkins P.J.: Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 20: 485-489, 1971.
9. Mitchell G.A., Kassovska-Bratinova S., Boukaftane Y.: Medical aspects of ketone body metabolism. Clin. Invest. Med. 18: 193-216, 1995.
10. Foster D.W., McGarry J.D.: The metabolic derangements and treatment of diabetic ketoacidosis. N. Engl. J. Med. 309: 159-169, 1983.
11. Khan A.S.A., Talbot J.A., Teszen K., Kaushal K., Siddals K.W., Gibson J.M., New J.P.: Beside ketone sensor retains accuracy despite changes in pH and the presence of potential interferents (Abstract). Diabetes 51 (Suppl. 2): A103, 2002.
12. Nadgir U.M., Silver F.L., MacGillivray M.H.: Unrecognized persistence of beta-hydroxybutyrate in diabetic ketoacidosis. Endocr. Res. 27: 41-46, 2001.
13. Davidson M.B.: Diabetic ketoacidosis and hyperosmolar non-ketotic syndrome. In: Davidson M.B. (Ed.), Diabetes mellitus diagnosis and treatment, 4th Ed. W.B. Saunders, Philadelphia, 1998, pp. 159-194.
14. May M.E., Young C., King J.: Resource utilization in treatment of diabetic ketoacidosis in adults. Am. J. Med Sci. 306: 287-294, 1993.
15. Pagano E., Brunetti M., Tediosi F., Garattini L.: Costs of diabetes. A methodological analysis of the literature. Pharmacoeconomics 15: 583-595, 1999.